Anticonvulsant effects of nimodipine alone and combination with phenytoin on MES induced seizures

Raina Jain, Ashish Jain


Background: To evaluate the anticonvulsant activity of Nimodipine alone and in combination with Phenytoin, in MES induced seizures.

Methods: The study was conducted in mice and MES seizure was induced by Techno electroconvulsometer. In first part of study, animals were treated with Nimodipine (20mg/kg i.p. and 40mg/kg i.p.) and Phenytoin (0.5 mg/100g i.p. and 1.0mg/100g i.p.), MES was induced and durations of various phases were noted. Duration of Tonic hind limb extension (THLE) was taken as index for antiepileptic activity. In second part, the animals were treated with combination of sub effective doses of Nimodipine (20mg/kg i.p.) and Phenytoin (0.5mg/100g i.p.), MES was induced and durations of various phases were noted.

Results: Nimodipine produced significant antiepileptic activity, in dose dependent manner. Phenytoin produced significant antiepileptic effect in dose of 1.0mg/100g but failed to produce any such effect in dose of 0.5mg/100g, when administered alone. But when sub effective doses.

Of Nimodipine and Phenytoin were combined, a synergistic effect was seen.

Conclusions: Nimodipine possess significant antiepileptic activity, alone, as well as it potentiates the antiepileptic effect of Phenytoin, suggesting the novel application of already proven safe and efficacious calcium channel blockers.


MES, Nimodipine, Phenytoin, Synergism, THLE

Full Text:



Bharrucha NE. Epidemiology of epilepsia in india. Epilepsia. 2003;44:9-11[pubmed].

Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: A community-based study with a comparison between urban and rural areas. Neuroepidemiology. 2004;23:261-8 [pubmed].

James O MC Namara. Drugs effective in the therapy of epilepsies. In Goodmann Gilmanˈs Pharmacological Basis of Therapeutic, Hardman JG, Limbard LE, Gilman AG, Mc Graw Hill, New York; 10th Edition; 2001:724-760.

Cheng LS, Prasad AN, Reider MJ. Relationship between antiepileptic drugs and biological markers affecting long term cardiovascular function in children and adolescents. Can J Clin Pharmacol. 2010;17:45-6 [pubmed].

Shehata GA, Bateh Ael-A, Hamed SA, Rageh TA, Elsorogy YB. Neurophysiological effects of antiepileptic drugs (carbamazepine verse valproate) in adult males with epilepsy. Neuropsychiatry Dis Treat. 2009;5:527-33 [pubmed].

Desai CK, Dikshit RK, Mansuri SM, Shah UH. Comparative evaluation of anticonvulsant activity of CCBs in experimental animals. Ind J of Experi, Mental Biology. 1995;33:931-34.

Larkin JG, Thompson GG, Scobie G, Forrest G, Drennan JE, Brodie MJ. Dihydropyridine calcium channel antagonists against pentylenetetrazole seizures, Epilepsia. 1992;33:760-9.

Hilmar B. Nuclear calcium activated gene expression: Possible roles in neuronal plasticity and epileptogenesis. Epilepsy Research. 1999;36:225-31.

Berg M, Bruhn T, Frandsen A, Schousboe A, Diemer NH. Kainic acid induced seizures and brain damage in the rat; Role of calcium homeostasis. J Neurusci Res. 1995;40:641-6.

Wurpel JN. Calcium channel blockers verapamil and nimodipine inhibit kindling in adult and immature rats. Epilepsia. 1994;35:443-9.

Palmer GC, Stagnitto ML, Ray RK, Knowles MA, Harvey R, Garske GE. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-L-aspartate and Bay 448644 induced convulsions are potently blocked by the dihydropyridines. Epilepsia. 1993;34:372-80.

Meyer FB, Anderson RE, Sundt TM, Sharbrough FW. Selective central nervous system calcium channel blockers- a new class of anticonvulsant agents. In Mayo Clinic Proceedings. Elsevier. 1986;61(4):239-47.

Gasior M, Kleinrok Z, Czuczwan SJ. Influence of BAY K - 8644, a calcium channel antagonist on the anticonvulsant activity of conventional antiepileptics against electroconvulsions in mice. Neuro Pharmacology. 1995;34(4):433-8.

De Sarro GB, Meldrum BS, Nistico G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol. 1988;93:247-56.

Rossier, Michel F. T type calcium channel: A priviledge gate for calcium entry and control of adrenal steroidogenesis. Frontiears in endocrinology.7. 2016.

Morocutti C, Pierelli F, Sanarelli L, Stefano E, Peppe A, Mattioli GL. Antiepileptic effects of a calcium channel antagonist (Nimodipine) on CFZ induced epileptic foci in rabbits. EPILEPSIA. 1986;27(5):498-503.

Mikati MA, Holmes GL, Werner S, Bakkar N, Carmant L, Stafstrom CE. Effects of Nimodipine on the behavioral sequelae of experimental status epilepticus in prepubescent rats. Epilepsy behaves. 2004;5(2):168-74.

Neil OSK, Bolger GT. The effects of dihydropyridine calcium channel modulators on PTZ. Brain Res Biull. 1990;25(1):211-4.

Ramírez-San Juan E, Soriano-Ursúa MA, Espinosa-Raya J, Correa-Basurto J, Trujillo-Ferrara JG, Miranda-Ruvalcaba R, et al. Anticonvulsant effects of bis-1, 4-dihydropyridines and the probable role of L-type calcium channels suggested by docking simulations. Medicinal Chemistry Research. 2014 Dec 1;23(12):5149-59.

Tartara A, Galimberti CA, Manni R, Parietti L, Zucca L, Laresia L, et al. Differential effects of valproic acid and enzyme including anticonvulsants on Nimpodipine pharmacokinetics in epileptic patients. Br J Clin Pharmacol. 1991;32:335-40 [pubmed].

Czuczwar SJ, Tutski L, Turski W, Kleinrok Z. Effects of some antiepileptic drugs in PTZ induced convulsions in mice lesioned wth kainic acid. Epilepsia.1981;22:407-14[pubmed].

Mclean MJ, Madonal RL. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J Pharmacol Exp Ther. 1983;227:779-89.

Narahashi T, Baker PF. Drugs acting on calcium channels. Handbook of experimental pharmacology. Vol. 83; Berlin Springer verlag. 1988:225-274.

Katzung BG. Basic and clinical pharmacology; 6th Edition. East Narwalk. Appleton and Lange, 1995;225-274.

Messing RO, Capenter CL, Greenberg DA: Mechanism of calcium channel inhibition by Phenytoin: Comparison with classical calcium antagonists. J Pharmacol Exp Ther. 1985;235(2):407-11.

Kryzhanovskii GN, Karpora MN, Abrosimov 2 U, Pankov OIU, Lakinia MV. The anticonvulsant activity of sodium valproate and various calcium antagonists during their combined use in mice. Biull Eksp Biol Med. 1993;115(3):231-3.